Management of Potassium Supplementation
Assessment and Rationale
- The patient is currently receiving oral potassium supplementation at a dose of 40 mmol TID, which is 120 mmol/day, and their previous home dose was 16 mmol/day, according to the European Society of Cardiology 1
- Continuing both IV and high-dose oral supplementation when potassium has normalized creates unnecessary risk of hyperkalemia, as stated by the American Heart Association 2
- The risk of continued aggressive supplementation outweighs benefits once normal levels are achieved, as recommended by the European Society of Cardiology 3
Monitoring and Maintenance
- Check serum potassium level within 24 hours to ensure stability, as advised by the American Heart Association 2
- Consider returning to the patient's home dose of 16 mmol/day if ongoing supplementation is needed, based on guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) 1
- For patients on digoxin, more careful monitoring is required as hypokalemia increases digitalis toxicity risk, according to the American College of Cardiology 4